Navigation Links
Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
Date:12/4/2008

PLEASANTON, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that a pre-specified interim analysis of data from its HeartMate II Destination Therapy (DT) pivotal trial shows that patients implanted with the device achieved statistically superior outcomes versus those in the control group who were implanted with the company's HeartMate XVE. The DT study protocol called for an interim analysis to test for overwhelming superiority when 67 percent of the first 200 randomized patients had reached two-years of follow up. The primary endpoint for the trial assessed in this analysis includes patients being alive, and free of stroke and the need of reoperation for device replacement at two years.

As a result of the data, the study's Data Safety Monitoring Board (DSMB) has concurred with Thoratec's plan to eliminate randomization for all additional patients enrolled in the DT study under the FDA-authorized Continuous Access Protocol (CAP). The company indicated that it will be filing an Investigational Device Exemption (IDE) Supplement with the FDA seeking approval for this action later this month, and that it now expects to file a PreMarket Approval (PMA) application seeking commercial approval of the HeartMate II for DT in the first half of 2009.

In May 2007, the company announced that it had achieved the required enrollment of 200 patients in the randomized portion of the trial. Since then, the company has continued to enroll patients under CAPs, including the most recent CAP approved by the FDA in mid-November allowing for enrollment of an additional 60 patients. As of October 24, 2008, the company had enrolled 607 patients in the trial, including 366 in the randomized p
'/>"/>

SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
3. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
6. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
7. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
8. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
9. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
10. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
11. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014   NuAire , a manufacturer of ergonomically ... with Hitachi Koki of Japan ... North America . NuAire will utilize its network of ... Canada to offer assistance in application use, ...
(Date:1/14/2014)... Oligomerix, Inc. , a privately held company pioneering the ... and related neurodegenerative disorders, announced today the relocation of ... as of January 15, 2014 and expanded lease ... College. Oligomerix, which is focused on the ...
(Date:1/14/2014)...   Evidera , a leading provider of evidence-based solutions ... Drug Evaluation and Research (CDER), U.S. Food and Drug ... for a patient-reported outcome (PRO) measure in drug development: ... [EXACT] for Measurement of Symptoms of Acute Bacterial Exacerbation ...
Breaking Medicine Technology:NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
(Date:4/17/2014)... as 10 million older Americans suffer from depression, often ... However, new research a project that followed the ... years found that Internet use among the elderly ... 30 percent. , "That,s a very strong effect," said ... information studies and media who led the project. "And ...
(Date:4/17/2014)... BostonResearchers from Boston University School of Medicine (BUSM) ... alcohol consumption in an experimental model. The findings, ... and Alcohol Abuse , may lead to more ... alcohol is one of the leading causes of ... significant negative economic impact by limiting the productivity ...
(Date:4/17/2014)... international research team led by Cesar A. Arias, M.D., ... at Houston (UTHealth) has identified a new superbug that ... report appeared in the April 17 issue of ... new superbug is part of a class of highly-resistant ... MRSA, which is a major cause of hospital and ...
(Date:4/17/2014)... alleviates muscle soreness after exercise, according to a ... at Chicago. , The study, reported online in ... Physical Medicine and Rehabilitation , also showed that ... not exercised, suggesting that massage has benefits for ... , Improved circulation and relief of muscle soreness ...
(Date:4/17/2014)... 17, 2014 Giving patients adrenaline after they suffer a ... their prospects of surviving long-term, according to new research ... of patients who have a cardiac arrest get adrenaline, ... arrest for decades," said Dr. Steve Lin, an emergency ... despite advances in medical treatment, long-term survival rates of ...
Breaking Medicine News(10 mins):Health News:Internet use can help ward off depression among elderly 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:New MRSA superbug emerges in Brazil 2Health News:Massage therapy improves circulation, eases muscle soreness 2Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2
... Acknowledges Decades of Service WILMINGTON, Del., May 1 ... the non-profit segment running smoothly in tough economic ... is making sure their volunteers get the recognition ... to premiere this spring, with a whimsical, permanent ...
... honors journalists for orthopaedic-related coverageROSEMONT, Ill., May 1 ... (AAOS) has announced the winners of its 2009 ... year and honors media efforts that further public understanding ... the care of bones, joints, muscles and tendons. ...
... this Sunday, May 3, 2009 for one of the country,s ... Millions were moved by his voice, now thousands more will ... Cook takes to a different kind of stage, leading ... Cassidy & Pinkard Colliers National Race for Hope, this Sunday, ...
... Offering of Avalign Technologies, Inc.LAKE FOREST, Ill., ... an operating-oriented private equity firm focused exclusively ... its portfolio company, Avalign Technologies, Inc. ... implants, and delivery systems to the OEM ...
... As H1N1 influenza A (swine flu) spreads, keeping hands ... prevent infection and illness. "Frequent handwashing is probably ... do to protect yourself and your family," according to ... Microbiology."Influenza A viruses, of which swine flu is one, ...
... Director,s Award presented at 2009 Dish benefitSAINT PAUL, ... Upper Midwest,s largest hunger-relief organization, has honored David ... Foundation and founder of the nation,s first food ... Award. The award recognizes outstanding individual contributions to ...
Cached Medicine News:Health News:Artist Contributes to Volunteer Recognition 2Health News:American Academy of Orthopaedic Surgeons Announces Media Orthopaedic Reporting Excellence (MORE) Award Winners 2Health News:American Academy of Orthopaedic Surgeons Announces Media Orthopaedic Reporting Excellence (MORE) Award Winners 3Health News:American Idol David Cook Headlines National Race for Hope 2Health News:RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition 2Health News:RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition 3Health News:American Society for Microbiology Emphasizes Hand Hygiene as Flu Protective Measure 2Health News:Second Harvest Heartland Honors Hunger Hero David Nasby 2Health News:Second Harvest Heartland Honors Hunger Hero David Nasby 3
Curved, soft flexible tip allows atraumatic entry through a retinal tear or hole for aspiration of subretinal fluids. 20 gauge x 25 mm cannula attached to 25 gauge x 6 mm tip with 13 mm flexible tubi...
20 gauge x 8 mm with 15 cm high pressure extension tube preattached to a 10C ring control syringe. 3 per box....
Sharp tip with cutting edge bent to 50 degrees fits 19 gauge or 20 gauge instrument port, 20 gauge instrument port, 20 gauge x 25 mm tapering to 25 gauge x 4.76 mm. 10 per box....
Angled, 20 gauge x 25 mm cannula with 30 gauge x 5 mm tip. 30 gauge cannula extends into hub 2 mm from end of hub, angled 45 degrees 2.5 mm from tip. 10 per box....
Medicine Products: